Consequently, the purpose of present study is to evaluate the possible correlation between the SGLT2 inhibitor administration and following EC incidence in T2DM population via the National Health Insurance Research Database (NHIRD) of Taiwan. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.